Albendazole Dosing in Adults
For most common intestinal parasitic infections in adults, the standard dose is 400 mg orally as a single dose, though specific conditions require different regimens ranging from 400 mg twice daily for 8-30 days (neurocysticercosis and hydatid disease) to single-dose therapy for simple helminth infections. 1, 2
Standard Single-Dose Regimens
For the following infections, administer albendazole 400 mg as a single oral dose with food:
- Ascariasis (roundworm): 400 mg single dose achieves 96-100% cure rates 1, 3, 4
- Hookworm infections (initial treatment): 400 mg single dose provides 90-96% cure rates for Ancylostoma duodenale and Necator americanus 1, 3
- Enterobiasis (pinworm): 400 mg single dose 1
Multi-Day Regimens for Specific Infections
For hookworm (complete treatment): 400 mg daily for 3 consecutive days to optimize cure rates 1, 3
For Strongyloidiasis: While ivermectin 200 μg/kg single dose is preferred, albendazole 400 mg twice daily for 3-7 days can serve as an alternative in patients with normal immunity 1
For Trichuriasis (whipworm): 600 mg single dose provides superior efficacy (60.9% cure rate) compared to 400 mg (27.3% cure rate), though mebendazole remains preferred 4
High-Dose Extended Regimens
For neurocysticercosis (parenchymal disease):
- Adults ≥60 kg: 400 mg twice daily with meals for 8-30 days 2
- Adults <60 kg: 15 mg/kg/day divided into two doses (maximum 800 mg/day) for 8-30 days 2
- Critical: Must administer concomitant corticosteroids and anticonvulsants to prevent cerebral hypertensive episodes during the first week 2, 5
- For 1-2 viable cysts: 15 mg/kg/day (maximum 1200 mg/day) for 10-14 days as monotherapy 5
- For >2 viable cysts: Combine albendazole 15 mg/kg/day with praziquantel 50 mg/kg/day for 10-14 days 5
For hydatid disease (echinococcosis):
- Adults ≥60 kg: 400 mg twice daily with meals 2
- Adults <60 kg: 15 mg/kg/day divided into two doses (maximum 800 mg/day) 2
- Duration: 28-day cycles followed by 14-day drug-free intervals, for a total of 3 cycles 2
For microsporidiosis (HIV/immunocompromised patients):
- 7.5 mg/kg twice daily (maximum 400 mg per dose) until immune reconstitution 5, 1
- More effective for Encephalitozoon intestinalis than Enterocytozoon bieneusi 5
For Loiasis (high microfilarial loads):
- 400 mg daily for 10-28 days when diethylcarbamazine is not feasible 1
- May escalate to 800 mg daily if treatment fails 1
Critical Administration Guidelines
Always administer albendazole with food to enhance absorption, as bioavailability increases significantly with fatty meals 2
Tablets may be crushed or chewed and swallowed with water for patients with difficulty swallowing 2
Essential Safety Monitoring
Before initiating therapy:
- Obtain baseline complete blood count and liver function tests 2
- Pregnancy test in all females of reproductive potential 2
- Screen for Loa loa infection in anyone with travel history to endemic regions before co-administering ivermectin, as this combination can cause severe adverse reactions 1, 6
During therapy (especially for extended regimens):
- Monitor blood counts at the beginning of each 28-day cycle and every 2 weeks during treatment 2
- Monitor liver enzymes at the beginning of each cycle and at least every 2 weeks 2
- Discontinue immediately if clinically significant cytopenias develop 2
Common Pitfalls to Avoid
Never use albendazole alone for neurocysticercosis without concomitant steroids and anticonvulsants, as parasite death triggers inflammatory reactions causing seizures and increased intracranial pressure 2, 5
Do not use single-dose therapy for hookworm in areas with high Necator americanus prevalence, as 3-day regimens provide superior cure rates 1
Exclude neurocysticercosis before treating intestinal Taenia solium infection, as killing intestinal tapeworms may release eggs that cause brain cysts 1
For patients requiring immunosuppression, screen for Strongyloides stercoralis first, as corticosteroids can precipitate fatal hyperinfection syndrome 6
Counsel females of reproductive potential to use effective contraception during treatment and for 3 days after the final dose due to teratogenic risk 2
Emerging Evidence on Higher Dosing
Recent data suggests 800 mg single dose in adults achieves 94.1% cure rates for hookworm compared to 74.9% with standard dosing, with no increase in adverse events 7. However, current guidelines have not yet incorporated this higher dosing for routine use, and 400 mg remains the standard recommendation 1, 2.